Overview


According to FutureWise analysis the market for arterial blood sampling systems is expected to reach US$ 2.10 billion by 2031 at a CAGR of 10.42%.

The arterial blood sampling system extracts oxygen (O2) and carbon dioxide (CO2) from arterial blood and instantly analyzes oxygen, carbon dioxide, and pH levels. Additionally, it measures how well the lungs move oxygen into the blood and remove carbon dioxide. It is also possible to perform arterial blood sampling in order to observe how the patient responds to the treatment. Professionals found it useful for determining whether a patient needs additional oxygen or other breathing assistance. Various conditions that may affect the lungs, heart, and kidneys can be diagnosed with arterial blood sampling devices, such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Kidney failure, diabetes problems such as hyperglycemic hyperosmolar state (HHS) and diabetic ketoacidosis (DKA), heart failure, infections or septicemia, poisoning, drug overdose, shock, and hemorrhage. The collection of arterial blood should be performed only by healthcare professionals who are properly trained and experienced in the procedure. To prevent infection to physicians and patients during blood sampling, arterial blood sampling systems must be sterilized. The most common method of collecting arterial blood is through the use of arterial blood collection devices. Increasing preference for arterial blood sampling systems in health care settings and shift to preventive healthcare have resulted in considerable demand for arterial blood sampling systems. Blood sampling systems market growth is expected to be boosted by technological advancements in arterial blood sampling systems. Increasing demand for safe arterial blood sampling to reduce blood wastage is driving the growth of the arterial blood sampling systems market. The market is also growing due to the growing geriatric population suffering from chronic diseases and the increasing demand for chronic disease diagnosis. In addition to the continuously increasing number of accidents and traumas, the huge demand for blood donations and blood components for diagnostic testing is driving the growth of the arterial blood sampling systems market. In addition, arterial blood sampling systems are used to collect blood samples before the date of the surgical procedure in order to avoid postponing the surgery. The preoperative patient is now required to receive blood elements. As a result, sterilized blood sampling systems are essential for collecting blood specimens, which contributes to the growth of this market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Arterial Blood Sampling Systems Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Arterial Blood Sampling Systems Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Nipro Medical Corporation
  • F. Hoffmann-La Roche Ltd.
  • Medtronic Plc.
  • Terumo Medical Corporation
  • Becton Dickinson
  • Narang Medical Ltd.
  • Radiometer India
  • Greiner Bio-One
  • SEKISUI Medical
  • Sarstedt, Improve-medical
  • F.L. Medical
  • Hongyu Medical
  • SANLI Medical and Health Service
  • Gong Dong
  • CDRICH
  • SZBOON

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Vacuum blood collection system
  • Microfluidic system
  • Blood Collection Tubes
  • Lancet
  • Needles
  • Others

By Indication

  • Diseases of the lungs
    • asthma
    • chronic obstructive pulmonary disease (COPD)
    • cystic fibrosis
    • Kidney failure
  • Diabetes complications
    • diabetic ketoacidosis (DKA)
    • hyperglycemic hyperosmolar state (HHS)
  • Severe infections or septicemia
  • Drug overdose
  • Poisoning
  • Heart failure
  • Haemorrhage
  • Shock

By End-user

  • Hospitals and clinics
  • Blood banks
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Arterial Blood Sampling Systems Market By Product Type, By Indication, By End-user and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions—North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping-product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Arterial Blood Sampling Systems Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Arterial Blood Sampling Systems Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Arterial Blood Sampling Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Arterial Blood Sampling Systems Market, By Product Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Vacuum blood collection system
        2. Microfluidic system
        3. Blood Collection Tubes
        4. Lancet
        5. Needles
        6. Others

  • 8.   Arterial Blood Sampling Systems Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diseases of the lungs
         1.1. asthma
         1.2. chronic obstructive pulmonary disease (COPD)
         1.3. cystic fibrosis
         1.4. Kidney failure
        2. Diabetes complications
         2.1. diabetic ketoacidosis (DKA)
         2.2. hyperglycemic hyperosmolar state (HHS)
        3. Severe infections or septicemia
        4. Drug overdose
        5. Poisoning
        6. Heart failure
        7. Haemorrhage
        8. Shock

  • 9.   Arterial Blood Sampling Systems Market, By End-user Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals and clinics
        2. Blood banks
        3. Others

  • 10.   North America Arterial Blood Sampling Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Arterial Blood Sampling Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Arterial Blood Sampling Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Arterial Blood Sampling Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Arterial Blood Sampling Systems Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Thermo Fisher Scientific, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Bio-Rad Laboratories, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Qiagen
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Nipro Medical Corporation
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. F. Hoffmann-La Roche Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Medtronic Plc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Terumo Medical Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Becton Dickinson
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Narang Medical Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Radiometer India
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
         11. Greiner Bio-One
          11.1. Company Overview
          11.2. Product Portfolio
          11.3. SWOT Analysis
          11.4. Financial Overview
          11.5. Strategic Overview
         12. SEKISUI Medical
          12.1. Company Overview
          12.2. Product Portfolio
          12.3. SWOT Analysis
          12.4. Financial Overview
          12.5. Strategic Overview
         13. Sarstedt, Improve-medical
          13.1. Company Overview
          13.2. Product Portfolio
          13.3. SWOT Analysis
          13.4. Financial Overview
          13.5. Strategic Overview
        14. F.L. Medical
          14.1. Company Overview
          14.2. Product Portfolio
          14.3. SWOT Analysis
          14.4. Financial Overview
          14.5. Strategic Overview
         15. Hongyu Medical
          15.1. Company Overview
          15.2. Product Portfolio
          15.3. SWOT Analysis
          15.4. Financial Overview
          15.5. Strategic Overview
         16. SANLI Medical & Health Service
          16.1. Company Overview
          16.2. Product Portfolio
          16.3. SWOT Analysis
          16.4. Financial Overview
          16.5. Strategic Overview
         17. Gong Dong
          17.1. Company Overview
          17.2. Product Portfolio
          17.3. SWOT Analysis
          17.4. Financial Overview
          17.5. Strategic Overview
         18. CDRICH
          18.1. Company Overview
          18.2. Product Portfolio
          18.3. SWOT Analysis
          18.4. Financial Overview
          18.5. Strategic Overview
         19. SZBOON
          19.1. Company Overview
          19.2. Product Portfolio
          19.3. SWOT Analysis
          19.4. Financial Overview
          19.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Arterial Blood Collection Devices Market

Read More
Partner

Our Clients